B
Beatriz Clares
Researcher at University of Granada
Publications - 72
Citations - 1919
Beatriz Clares is an academic researcher from University of Granada. The author has contributed to research in topics: In vivo & Drug delivery. The author has an hindex of 22, co-authored 71 publications receiving 1469 citations. Previous affiliations of Beatriz Clares include University of Barcelona & Andalusian Health Service.
Papers
More filters
Journal ArticleDOI
Current encapsulation strategies for bioactive oils: From alimentary to pharmaceutical perspectives
TL;DR: An overview on the different systems for the encapsulation of bioactive oils, as well as, the elaboration methods currently utilized can be found in this article, where the authors state that encapsulation is one of the most efficient methods for the formulation of Bioactive oils and various investigations have been developed.
Journal ArticleDOI
Evaluating the Oxidative Stress in Inflammation: Role of Melatonin.
TL;DR: Melatonin, a hormone secreted by the pineal gland, that works directly and indirectly as a free radical scavenger, like a potent antioxidant, is described.
Journal ArticleDOI
Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: Effect on skin permeation
Beatriz Clares,Ana C. Calpena,Alexander Parra,Guadalupe Abrego,Helen L. Alvarado,Joana F. Fangueiro,Eliana B. Souto +6 more
TL;DR: Encouraging findings can guide in proper selection of topical carriers among the diversity of available lipid-based nanocarriers, especially when a dermatologic or cosmetic purpose is desired.
Journal ArticleDOI
Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
Joana F. Fangueiro,Ana C. Calpena,Beatriz Clares,Tatiana Andreani,M.A. Egea,Francisco Veiga,Maria Luisa García,Amélia M. Silva,Eliana B. Souto +8 more
TL;DR: Loading EGCG in cationic LNs is recognised as a promising strategy for the treatment of ocular diseases related to anti-oxidant and anti-inflammatory pathways.
Journal ArticleDOI
Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer.
Beatriz Clares,Rafael A. Biedma-Ortiz,E. Sáez-Fernández,Jose Prados,Consolación Melguizo,Laura Cabeza,Raúl Ortiz,José L. Arias +7 more
TL;DR: It is put forward that magnetoliposome particles hold important properties, that is, magnetically targeted delivery,hyperthermia inducing capability, high 5-fluorouracil loading capability, and hyperthermia-triggered burst drug release, suggestive of their potential for a combined antitumor therapy against colon cancer.